• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【药物名称】Sirolimus, Rapamycin, Wy-090217, AY-22989, Rapamune

【化学名称】[1R,9S,12S[1'R(1''S,3''R,4''R)],15R,18R,19R,21R,23S,30S,32S,35R]-1,18-Dihydroxy-12-[2-(4-hydroxy-3-methoxy-1-cyclohexyl)-1-methylethyl]-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.0(4,9)]hexatriaconta-16(E),24(E),26(E),28(E)-tetraen-2,3,10,14,20-pentaone
      (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hexadecahydro-9,27-dihydroxy-3-[2-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1(R)-methylethyl]-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-23,27-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentaone

【CA登记号】53123-88-9

【 分 子 式 】C51H79NO13

【 分 子 量 】914.19718

【开发单位】Wyeth Pharmaceuticals (Originator)

【药理作用】IMMUNOMODULATING AGENTS, Immunosuppressants, Treatment of Transplant Rejection, Inhibitors of Signal Transduction Pathways, mTOR Inhibitors

合成路线1

 

1 Ruppen ME, Charbonmneau PF. 2005. Labeling of rapamycin using rapamycin-specific methylases. US 2005239178(本专利属于Wyeth,John, and Brother Ltd.USA)
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 66699     C50H77NO13 详情 详情
(II) 66700 (2S)-2-amino-4-((((3S,4R)-5-(6-amino-7H-purin-9(8H)-yl)-3,4-dimethyltetrahydrofuran-2-yl)methyl)(methyl)sulfonio)butanoate   C17H28N6O3S 详情 详情

合成路线2

 

1 Adamczky M, Gebler JC, Mattingly PG. 1994.Lipase mediated hydrolysis 42-hemisuccinate benzyl and methyl esters. Tetnhedron Lett, 35: 1019~1022
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 66701     C55H83NO16 详情 详情

合成路线3

A partial synthesis of rapamycin has been reported: The condensation of sulfone (I) with epoxide (II) by means of butyllithium followed by desulfonation with Na/Hg gives the partially protected diol (III), which is treated with methanesulfonyl chloride and NaH to afford the epoxide (IV). Ring opening of epoxide (IV) with LiI and BF3.Et2O followed by protection of the resulting alcohol with PMBOC(NH)CCl3 yields the primary iodo compound (V). The condensation of (V) with the fully protected dihydroxyaldehyde (VI) (see later) by means of butyllithium in THF/HMPT gives the fully protected trihydroxyketone (VII), which is hydrolyzed with camphorsulfonic acid (CSA) to the corresponding gemdiol and reprotected with pivaloyl chloride (the primary alcohol) and tert-butyldimethylsilyl trifluoromethanesulfonate (the secondary alcohol), yielding a new fully protected trihydroxyketone (VIII). Elimination of the pivaloyl group with DIBAL and the dithiane group with MeI/CaCO3 affords the hydroxyketone (IX), which is finally oxidized with oxalyl chloride to the ketoaldehyde (X), the C(27)-C(42) fragment [the C(12)-C(15) fragment with the C(12)-substituent based on the IUPAC nomenclature recommendations]. The fully protected dihydroxyaldehyde (VI) is obtained as follows: The reaction of methyl 3-hydroxy-2(R)-methylpropionate (XI) with BPSCl followed by reduction with LiBH4 to the corresponding alcohol and oxidation with oxalyl chloride gives the aldehyde (XII), which is protected with propane-1,3-dithiol and BF3.Et2O to afford the dithiane compound (XIII). Elimination of the silyl group with TBAF followed by esterification with tosyl chloride, reaction with NaI and, finally, with sodium phenylsulfinate gives the sulfone (XIV), which is condensed with the partially protected dihydroxyaldehyde (XV), oxidized with oxalyl chloride and desulfonated with Al/Hg to afford the dithianyl ketone (XVI). The reaction of (XVI) with lithium hexamethyldisilylazane gives the corresponding enolate, which is treated with dimethyllithium cuprate to yield the fully protected unsaturated dihydroxyaldehyde (VI).

1 Leahy, J.W.; Smith, A.B.; McCauley, J.A.; Condon, S.M.; Leazer, J.L.; Maleczka, R.E.; Rapamycin synthetic studies. 1. Construction of the C(27)-C(42) subunit. Tetrahedron Lett 1994, 35, 28, 4907.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
52385 [4-(methyloxy)phenyl]methyl 2,2,2-trichloroethanimidoate C10H10Cl3NO2 详情 详情
(I) 14955 triisopropyl([(1R,2R,4R)-2-methoxy-4-[(phenylsulfonyl)methyl]cyclohexyl]oxy)silane; [(1R,3R,4R)-3-methoxy-4-[(triisopropylsilyl)oxy]cyclohexyl]methyl phenyl sulfone C23H40O4SSi 详情 详情
(II) 14956 tert-butyl[[(2R,3R)-3-methyloxiranyl]methoxy]diphenylsilane; tert-butyl(diphenyl)silyl [(2R,3R)-3-methyloxiranyl]methyl ether C20H26O2Si 详情 详情
(III) 14957 (2S,3R)-1-[[tert-butyl(diphenyl)silyl]oxy]-4-[(1S,3R,4R)-3-methoxy-4-[(triisopropylsilyl)oxy]cyclohexyl]-3-methyl-2-butanol C37H62O4Si2 详情 详情
(IV) 14958 triisopropyl[((1R,2R,4S)-2-methoxy-4-[(2R)-2-[(2S)oxiranyl]propyl]cyclohexyl)oxy]silane; (1R,2R,4S)-2-methoxy-4-[(2R)-2-[(2S)oxiranyl]propyl]cyclohexyl triisopropylsilyl ether C21H42O3Si 详情 详情
(V) 14959 [((1R,2R,4S)-4-[(2R,3R)-4-iodo-3-[(4-methoxybenzyl)oxy]-2-methylbutyl]-2-methoxycyclohexyl)oxy](triisopropyl)silane; (1R,2R,4S)-4-[(2R,3R)-4-iodo-3-[(4-methoxybenzyl)oxy]-2-methylbutyl]-2-methoxycyclohexyl triisopropylsilyl ether C29H51IO4Si 详情 详情
(VI) 14960 (4R)-4-[(E,3R)-3-(1,3-dithian-2-yl)-1-methyl-1-butenyl]-2,2-dimethyl-1,3-dioxolane C14H24O2S2 详情 详情
(VII) 14961 (1R,2R,4S)-4-[(2R,3S)-4-(2-[(1R,2E)-3-[(4R)-2,2-dimethyl-1,3-dioxolan-4-yl]-1-methyl-2-butenyl]-1,3-dithian-2-yl)-3-[(4-methoxybenzyl)oxy]-2-methylbutyl]-2-[(triisopropylsilyl)oxy]cyclohexanol C42H72O6S2Si 详情 详情
(VIII) 14962 (2R,3E,5R)-2-[[tert-butyl(dimethyl)silyl]oxy]-5-[2-((2S,3R)-2-[(4-methoxybenzyl)oxy]-4-[(1S,3R,4R)-3-methoxy-4-[(triisopropylsilyl)oxy]cyclohexyl]-3-methylbutyl)-1,3-dithian-2-yl]-3-methyl-3-hexenyl pivalate C51H92O7S2Si2 详情 详情
(IX) 14963 (2R,3S,6R,7E,9R)-9-[[tert-butyl(dimethyl)silyl]oxy]-10-hydroxy-3-[(4-methoxybenzyl)oxy]-1-[(1S,3R,4R)-3-methoxy-4-[(triisopropylsilyl)oxy]cyclohexyl]-2,6,8-trimethyl-7-decen-5-one C43H78O7Si2 详情 详情
(X) 14964 (2R,3E,5R,8S,9R)-1-[[tert-butyl(dimethyl)silyl]oxy]-7-[(4-methoxybenzyl)oxy]-9-[(1S,3R,4R)-3-methoxy-4-[(triisopropylsilyl)oxy]cyclohexyl]-2,4,8-trimethyl-5-oxo-3-decenoic 1,1-dimethylpropionic anhydride C48H84O9Si2 详情 详情
(XI) 14965 methyl 3-hydroxy-2-methylpropanoate; METHYL (S)-(+)-3-HYDROXY-2-METHYLPROPIONATE 80657-57-4 C5H10O3 详情 详情
(XII) 14966 (2R)-3-[[tert-butyl(diphenyl)silyl]oxy]-2-methylpropanal C20H26O2Si 详情 详情
(XIII) 14967 tert-butyl[[(2R)-2-(1,3-dithian-2-yl)propyl]oxy]diphenylsilane; tert-butyl(diphenyl)silyl (2R)-2-(1,3-dithian-2-yl)propyl ether C23H32OS2Si 详情 详情
(XIV) 14968 (2R)-2-(1,3-dithian-2-yl)propyl phenyl sulfone; 2-[(1R)-1-methyl-2-(phenylsulfonyl)ethyl]-1,3-dithiane C13H18O2S3 详情 详情
(XV) 14969 (4S)-2,2-dimethyl-1,3-dioxolane-4-carbaldehyde 22323-80-4 C6H10O3 详情 详情
(XVI) 14970 (3R)-1-[(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]-3-(1,3-dithian-2-yl)-1-butanone C13H22O3S2 详情 详情

合成路线4

A partial synthesis of rapamycin has been reported: The reaction of 1-(trimethylsilyl)-1,3-pentadiyne (I) with a stannyl cuprate gives a mixture of (E)- and (Z)-stannyl derivatives (II) and (III) [the ratio (II)/(III) depends on the stannyl cuprate used]. Both compounds, after chromatographic separation, are condensed with the chiral aldehyde (IV) by means of butyllithium to afford the alcohols (V) and (VI), respectively. By chromatographic separation of the corresponding (S)-isomers, these are methylated and deprotected with methyl iodide and KOH, yielding the (E)- and (Z)-isomeric terminal acetylenes (VII) and (VIII). The reaction of either (VII) or (VIII) with tributylstannyl hydride and AIBN in refluxing toluene gives in both cases the (E,E)-dienylstannane (IX), which by reaction with I2 in dichloromethane affords the (E,E)-dienyl iodide (X). Finally, this compound is condensed with the vinyl iodide (XI) (see later) by means of PdCl2 in DMF to yield (XII), the protected C(10)-C(26) fragment of rapamycin [the C(20)-C(35)-C(1)-O(36) fragment based on the IUPAC nomenclature recommendations].

1 Maleczka, R.E.; Condon, S.M.; Leazer, J.L.; McCauley, J.A.; Smith, A.B.; Leahy, J.W.; Rapamycin synthetic studies. 2. Elaboration of the C(10)-C(26) perimeter. Tetrahedron Lett 1994, 35, 28, 4911.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 14971 trimethyl(1,3-pentadiynyl)silane C8H12Si 详情 详情
(II) 14972 trimethyl[(E)-4-(tributylstannyl)-3-penten-1-ynyl]silane C20H40SiSn 详情 详情
(III) 14973 trimethyl[(Z)-4-(tributylstannyl)-3-penten-1-ynyl]silane C20H40SiSn 详情 详情
(IV) 14974 2-[(2R,3R,7S,10R)-2,3,10-trimethyl-1,4,6-trioxaspiro[4.5]dec-7-yl]acetaldehyde C12H20O4 详情 详情
(V) 14975 (E)-3-methyl-6-(trimethylsilyl)-1-[(2R,3R,7S,10R)-2,3,10-trimethyl-1,4,6-trioxaspiro[4.5]dec-7-yl]-3-hexen-5-yn-2-ol C20H34O4Si 详情 详情
(VI) 14976 (Z)-3-methyl-6-(trimethylsilyl)-1-[(2R,3R,7S,10R)-2,3,10-trimethyl-1,4,6-trioxaspiro[4.5]dec-7-yl]-3-hexen-5-yn-2-ol C20H34O4Si 详情 详情
(VII) 14977 methyl (1S,2E)-2-methyl-1-[[(2R,3R,7S,10R)-2,3,10-trimethyl-1,4,6-trioxaspiro[4.5]dec-7-yl]methyl]-2-penten-4-ynyl ether; (2R,3R,7S,10R)-7-[(2S,3E)-2-methoxy-3-methyl-3-hexen-5-ynyl]-2,3,10-trimethyl-1,4,6-trioxaspiro[4.5]decane C18H28O4 详情 详情
(VIII) 63930 (2R,3R,7S,10R)-7-[(2S,3Z)-2-methoxy-3-methyl-3-hexen-5-ynyl]-2,3,10-trimethyl-1,4,6-trioxaspiro[4.5]decane; methyl (1S,2Z)-2-methyl-1-{[(2R,3R,7S,10R)-2,3,10-trimethyl-1,4,6-trioxaspiro[4.5]dec-7-yl]methyl}-2-penten-4-ynyl ether C18H28O4 详情 详情
(IX) 14979 tributyl[(1E,3E,5S)-5-methoxy-4-methyl-6-[(2R,3R,7S,10R)-2,3,10-trimethyl-1,4,6-trioxaspiro[4.5]dec-7-yl]-1,3-hexadienyl]stannane C30H56O4Sn 详情 详情
(X) 14980 (1S,2E,4E)-5-iodo-2-methyl-1-[[(2R,3R,7S,10R)-2,3,10-trimethyl-1,4,6-trioxaspiro[4.5]dec-7-yl]methyl]-2,4-pentadienyl methyl ether; (2R,3R,7S,10R)-7-[(2S,3E,5E)-6-iodo-2-methoxy-3-methyl-3,5-hexadienyl]-2,3,10-trimethyl-1,4,6-trioxaspiro[4.5]decane C18H29IO4 详情 详情
(XI) 14981 tributyl[(E,3S,5R)-5-(1,3-dithian-2-yl)-3-methyl-1-hexenyl]stannane C23H46S2Sn 详情 详情
(XII) 14982 (2R,3R,7S,10R)-7-[(2S,3E,5E,7E,9S,11R)-11-(1,3-dithian-2-yl)-2-methoxy-3,9-dimethyl-3,5,7-dodecatrienyl]-2,3,10-trimethyl-1,4,6-trioxaspiro[4.5]decane; (1S,2E,4E,6E,8S,10R)-10-(1,3-dithian-2-yl)-2,8-dimethyl-1-[[(2R,3R,7S,10R)-2,3,10-trimethyl-1,4,6-trioxaspiro[4.5]dec-7-yl]methyl]-2,4,6-undecatrienyl methyl ether C29H48O4S2 详情 详情

合成路线5

The vinyl stannane fragment (XI) of the preceding synthesis (scheme 1756502a) is obtained as follows: Treatment of the meso-2,3-dimethylglutaric acid dimethyl ester (XIII) with alpha-chymotrypsin followed by reduction with borane.dimethylsulfide gives the chiral hydroxy ester (XIV), which is protected with BPSCl and the ester group reduced with DIBAL to afford the partially protected diol (XV). The oxidation of (XV) with oxalyl chloride and protection of the resulting aldehyde with propane-1,3-dithiol give the dithiane (XVI), which is deprotected with TBAF and oxidized with oxalyl chloride to yield the aldehyde (XVII). The olefination of (XVII) with methyl iodide and CrCl2 affords the trans-vinyl iodide (XVIII), which is finally treated with butyllithium and tributylstannyl bromide in ethyl ether to give the vinyl stannane fragment (XI).

1 Maleczka, R.E.; Condon, S.M.; Leazer, J.L.; McCauley, J.A.; Smith, A.B.; Leahy, J.W.; Rapamycin synthetic studies. 2. Elaboration of the C(10)-C(26) perimeter. Tetrahedron Lett 1994, 35, 28, 4911.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(XI) 14981 tributyl[(E,3S,5R)-5-(1,3-dithian-2-yl)-3-methyl-1-hexenyl]stannane C23H46S2Sn 详情 详情
(XIII) 14983 dimethyl (2R,4S)-2,4-dimethylpentanedioate C9H16O4 详情 详情
(XIV) 14984 methyl (2R,4S)-5-hydroxy-2,4-dimethylpentanoate C8H16O3 详情 详情
(XV) 14985 (2R,4S)-5-[[tert-butyl(diphenyl)silyl]oxy]-2,4-dimethyl-1-pentanol C23H34O2Si 详情 详情
(XVI) 14986 tert-butyl(diphenyl)silyl (2S,4R)-4-(1,3-dithian-2-yl)-2-methylpentyl ether; tert-butyl[[(2S,4R)-4-(1,3-dithian-2-yl)-2-methylpentyl]oxy]diphenylsilane C26H38OS2Si 详情 详情
(XVII) 14987 (3S,5R)-5-(1,3-dithian-2-yl)-3-methylhexanal C11H20OS2 详情 详情
(XVIII) 14988 2-[(1R,3S,4E)-5-iodo-1,3-dimethyl-4-pentenyl]-1,3-dithiane C11H19IS2 详情 详情

合成路线6

The total synthesis of rapamycin has been performed by initial condensation of two previously synthesized intermediates, the carboxylic acid (I) (scheme 17565203b) and the piperidine (II) (scheme 17565203c), by means of diisopropylcarbodiimide (DIC) and 1-hydroxybenzotriazole (HBT) in dichloromethane to the acylated piperidine (III). The two free hydroxyl groups of (III) are oxidized with oxalyl chloride in DMSO/dichloromethane to the triketone (IV), which is selectively deprotected with HF - pyridine in THF and oxidized again with oxalyl chloride to the hexacarbonyl compound (V). The full deprotection of (V) with HF in acetonitrile produces the simultaneous cyclization of the tetrahydropyran ring, yielding (VI), which is finally cyclized to rapamycin with the distannane (VII) by means of diisopropylethylamine (IEN) and palladium dichloride acetonitrile complex in DMF/THF. (1,2)

1 Nicolaou, K.C.; Piscopio, A.D.; Bertinato, P.; Chakraborty, T.K.; Minowa, N.; Koide, K.; Total Synthesis of Rapamycin. Chemistry (Weinheim) 1995, 1, 5, 318.
2 Nicolaou, K.C.; Chakraborty, T.K.; Piscopio, A.D.; Minowa, N.; Bertinato, P.; Total synthesis of rapamycin. J Am Chem Soc 1993, 115, 10, 4419.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 14989 (2R,3S,4R,7S,9S,10E)-2,3-dihydroxy-11-iodo-9-methoxy-4,10-dimethyl-7-[(triisopropylsilyl)oxy]-10-undecenoic acid C23H45IO6Si 详情 详情
(II) 14990 (1S,3S,4R,5E,7R,8R,9R,10R,12S,13E)-1-[(1R)-2-((1S,3R,4R)-4-[[tert-butyl(diphenyl)silyl]oxy]-3-methoxycyclohexyl)-1-methylethyl]-14-iodo-8-methoxy-4,6,10,12-tetramethyl-3,9-bis(triethylsilyl)-7-[(triisopropylsilyl)oxy]-5,13-tetradecadienyl (2S)-2-piperidinecarboxylate C72H128INO6Si4 详情 详情
(III) 14991 (1S,3S,4R,5E,7R,8R,9R,10R,12S,13E)-1-[(1R)-2-((1S,3R,4R)-4-[[tert-butyl(diphenyl)silyl]oxy]-3-methoxycyclohexyl)-1-methylethyl]-14-iodo-8-methoxy-4,6,10,12-tetramethyl-3,9-bis(triethylsilyl)-7-[(triisopropylsilyl)oxy]-5,13-tetradecadienyl (2S)-1-[(2R,3S,4R,7S,9S,10E)-2,3-dihydroxy-11-iodo-9-methoxy-4,10-dimethyl-7-[(triisopropylsilyl)oxy]-10-undecenoyl]-2-piperidinecarboxylate C95H171I2NO11Si5 详情 详情
(IV) 14992 (1S,3S,4R,5E,7R,8R,9R,10R,12S,13E)-1-[(1R)-2-((1S,3R,4R)-4-[[tert-butyl(diphenyl)silyl]oxy]-3-methoxycyclohexyl)-1-methylethyl]-14-iodo-8-methoxy-4,6,10,12-tetramethyl-3,9-bis(triethylsilyl)-7-[(triisopropylsilyl)oxy]-5,13-tetradecadienyl (2S)-1-[(4R,7S,9S,10E)-11-iodo-9-methoxy-4,10-dimethyl-2,3-dioxo-7-[(triisopropylsilyl)oxy]-10-undecenoyl]-2-piperidinecarboxylate C95H167I2NO11Si5 详情 详情
(V) 14993 (1S,4R,5E,7R,8R,10R,12S,13E)-1-[(1R)-2-((1S,3R,4R)-4-[[tert-butyl(diphenyl)silyl]oxy]-3-methoxycyclohexyl)-1-methylethyl]-14-iodo-8-methoxy-4,6,10,12-tetramethyl-3,9-dioxo-7-[(triisopropylsilyl)oxy]-5,13-tetradecadienyl (2S)-1-[(4R,7S,9S,10E)-11-iodo-9-methoxy-4,10-dimethyl-2,3-dioxo-7-[(triisopropylsilyl)oxy]-10-undecenoyl]-2-piperidinecarboxylate C83H135I2NO13Si3 详情 详情
(VI) 14994 (1S,4R,5E,7R,8R,10R,12S,13E)-1-[(1R)-2-((1S,3R,4R)-4-[[tert-butyl(dimethyl)silyl]oxy]-3-methoxycyclohexyl)-1-methylethyl]-14-iodo-8-methoxy-4,6,10,12-tetramethyl-3,9-dioxo-7-[(triisopropylsilyl)oxy]-5,13-tetradecadienyl (2S)-1-[(4R,7S,9S,10E)-11-iodo-9-methoxy-4,10-dimethyl-2,3-dioxo-7-[(triisopropylsilyl)oxy]-10-undecenoyl]-2-piperidinecarboxylate C73H131I2NO13Si3 详情 详情
(VII) 14995 tributyl[(E)-2-(tributylstannyl)ethenyl]stannane C26H56Sn2 详情 详情

合成路线7

The intermediates (I) and (II) are synthesized as follows: Intermediate (I): The carboxylic acid (VIII) is condensed with N-methoxy-N-methylamine by means of dicyclohexylcarbodiimide (DCC) in dichloromethane to the amide (IX), which is treated with the vinyl iodide (X) and butyllithium in ethyl ether to yield the ketone (XI). The reduction of (XI) with LiAlH4 followed by methylation with MeI and NaH in DMF affords the methoxy compound (XII), which by treatment with camphorsulfonic acid (CSA), triethylamine and K2CO3 in methanol is converted to the epoxide (XIII). The condensation of (XIII) with the iodo ether (XIV) by means of butyllithium followed by silylation with triisopropylsilyl trifluoromethanesulfonate in dichloromethane and iodination with N-iodosuccinimide (NIS) in THF gives the protected triol (XV), which is selectively oxidized with 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ) and oxalyl chloride in DMSO/dichloromethane, yielding the aldehyde (XVI). The condensation of (XVI) with the oxazolidinone (XVII) by means of tributylboron trifluoromethanesulfonate in toluene/dichloromethane affords compound (XVIII), which is treated with LiOH and H2O2 in THF/water. The resulting free acid is methylated with diazomethane, and the free hydroxyl group is acetylated with acetic anhydride to the acetoxy ester (XIX). Finally, (XIX) is hydrolyzed with LiOH in methanol/water to afford intermediate (I) (see A.D. Piscopio et al., J Chem Soc Chem Commun 1993, 7: 617). (1,2)

1 Nicolaou, K.C.; Piscopio, A.D.; Bertinato, P.; Chakraborty, T.K.; Minowa, N.; Koide, K.; Total Synthesis of Rapamycin. Chemistry (Weinheim) 1995, 1, 5, 318.
2 Nicolaou, K.C.; Chakraborty, T.K.; Piscopio, A.D.; Minowa, N.; Bertinato, P.; Total synthesis of rapamycin. J Am Chem Soc 1993, 115, 10, 4419.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 14989 (2R,3S,4R,7S,9S,10E)-2,3-dihydroxy-11-iodo-9-methoxy-4,10-dimethyl-7-[(triisopropylsilyl)oxy]-10-undecenoic acid C23H45IO6Si 详情 详情
(VIII) 14996 2-[(4R)-2,2-dimethyl-1,3-dioxolan-4-yl]acetic acid C7H12O4 详情 详情
(IX) 14997 2-[(4R)-2,2-dimethyl-1,3-dioxolan-4-yl]-N-methoxy-N-methylacetamide C9H17NO4 详情 详情
(X) 14998 [(E)-2-iodo-1-propenyl](trimethyl)silane C6H13ISi 详情 详情
(XI) 14999 (E)-1-[(4R)-2,2-dimethyl-1,3-dioxolan-4-yl]-3-methyl-4-(trimethylsilyl)-3-buten-2-one C13H24O3Si 详情 详情
(XII) 15000 [(E,3S)-4-[(4R)-2,2-dimethyl-1,3-dioxolan-4-yl]-3-methoxy-2-methyl-1-butenyl](trimethyl)silane; (1S,2E)-1-[[(4R)-2,2-dimethyl-1,3-dioxolan-4-yl]methyl]-2-methyl-3-(trimethylsilyl)-2-propenyl methyl ether C14H28O3Si 详情 详情
(XIII) 15001 methyl (1S,2E)-2-methyl-1-[(2R)oxiranylmethyl]-3-(trimethylsilyl)-2-propenyl ether; [(E,3S)-3-methoxy-2-methyl-4-[(2R)oxiranyl]-1-butenyl](trimethyl)silane C11H22O2Si 详情 详情
(XIV) 15002 (2S)-3-iodo-2-methylpropyl 4-methoxybenzyl ether; 1-([[(2S)-3-iodo-2-methylpropyl]oxy]methyl)-4-methoxybenzene C12H17IO2 详情 详情
(XV) 15003 [((1S,3S,4E)-5-iodo-3-methoxy-1-[(3R)-4-[(4-methoxybenzyl)oxy]-3-methylbutyl]-4-methyl-4-pentenyl)oxy](triisopropyl)silane; (1S,2E)-3-iodo-1-[(2S,5R)-6-[(4-methoxybenzyl)oxy]-5-methyl-2-[(triisopropylsilyl)oxy]hexyl]-2-methyl-2-propenyl methyl ether C29H51IO4Si 详情 详情
(XVI) 15004 (2R,5S,7S,8E)-9-iodo-7-methoxy-2,8-dimethyl-5-[(triisopropylsilyl)oxy]-8-nonenal C21H41IO3Si 详情 详情
(XVII) 15005 (4R,5S)-3-[2-[(4-methoxybenzyl)oxy]acetyl]-4-methyl-5-phenyl-1,3-oxazolan-2-one C20H21NO5 详情 详情
(XVIII) 15006 (4R,5S)-3-[(2R,3S,4R,7S,9S,10E)-3-hydroxy-11-iodo-9-methoxy-2-[(4-methoxybenzyl)oxy]-4,10-dimethyl-7-[(triisopropylsilyl)oxy]-10-undecenoyl]-4-methyl-5-phenyl-1,3-oxazolidin-2-one C41H62INO8Si 详情 详情
(XIX) 15007 methyl (2R,3S,4R,7S,9S,10E)-3-(acetoxy)-2-hydroxy-11-iodo-9-methoxy-4,10-dimethyl-7-[(triisopropylsilyl)oxy]-10-undecenoate C26H49IO7Si 详情 详情

合成路线8

Intermediate (II): Compound (II) is obtained starting from two new previously synthesized intermediates, the oxazolidinone (XX) (scheme 17565203d) and the aldehyde (XXI) (scheme 17565203e), which are condensed by means of dibutylboron trifluoromethanesulfonate in dichloromethane to give compound (XXII), which is reduced first with LiBH4, tosylated with tosyl chloride and reduced again with lithium triethylborohydride in THF to yield compound (XXIII). The esterification of (XXIII) with the piperidine-2-carboxylic acid (XXIV) by means of DIC in dichloromethane followed by iodination of the terminal vinyl group by means of OsO4-catalyzed diol formation - Pb(OAc)4 cleavage, followed by CrCl2-mediated iodo-olefination with triiodomethane in THF/dioxane, affords the iodovinyl ester (XXV). Finally, (XXV) is debenzylated with DDQ in CHCl3 and silylated with triethylsilyl trifluoromethanesulfonate in dichloromethane to afford intermediate (II) (see K.C. Nicolau et al., J Chem Soc Chem Commun 1993, 7: 619). (1,2)

1 Nicolaou, K.C.; Piscopio, A.D.; Bertinato, P.; Chakraborty, T.K.; Minowa, N.; Koide, K.; Total Synthesis of Rapamycin. Chemistry (Weinheim) 1995, 1, 5, 318.
2 Nicolaou, K.C.; Chakraborty, T.K.; Piscopio, A.D.; Minowa, N.; Bertinato, P.; Total synthesis of rapamycin. J Am Chem Soc 1993, 115, 10, 4419.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(II) 14990 (1S,3S,4R,5E,7R,8R,9R,10R,12S,13E)-1-[(1R)-2-((1S,3R,4R)-4-[[tert-butyl(diphenyl)silyl]oxy]-3-methoxycyclohexyl)-1-methylethyl]-14-iodo-8-methoxy-4,6,10,12-tetramethyl-3,9-bis(triethylsilyl)-7-[(triisopropylsilyl)oxy]-5,13-tetradecadienyl (2S)-2-piperidinecarboxylate C72H128INO6Si4 详情 详情
(XX) 15008 (4R,5S)-3-[3-((1S,3R)-4-[[tert-butyl(diphenyl)silyl]oxy]-3-methoxycyclohexyl)propanoyl]-4-methyl-5-phenyl-1,3-oxazolidin-2-one C36H45NO5Si 详情 详情
(XXI) 15009 (3S,4R,5E,7R,8S,9R,10R,12S)-8-methoxy-3,9-bis[(4-methoxybenzyl)oxy]-4,6,10,12-tetramethyl-7-[(triisopropylsilyl)oxy]-5,13-tetradecadienal C44H70O7Si 详情 详情
(XXII) 15010 (4R,5S)-3-[(2R,3S,5S,6R,7E,9R,10S,11R,12R,14S)-2-[((1S,3R,4R)-4-[[tert-butyl(diphenyl)silyl]oxy]-3-methoxycyclohexyl)methyl]-3-hydroxy-10-methoxy-5,11-bis[(4-methoxybenzyl)oxy]-6,8,12,14-tetramethyl-9-[(triisopropylsilyl)oxy]-7,15-hexadecadienoyl]-4-methyl-5-phenyl-1,3-oxazolidin-2-one C80H115NO12Si2 详情 详情
(XXIII) 15011 (2R,3S,5S,6R,7E,9R,10S,11R,12R,14S)-1-((1S,3R,4R)-4-[[tert-butyl(diphenyl)silyl]oxy]-3-methoxycyclohexyl)-10-methoxy-5,11-bis[(4-methoxybenzyl)oxy]-2,6,8,12,14-pentamethyl-9-[(triisopropylsilyl)oxy]-7,15-hexadecadien-3-ol C70H108O9Si2 详情 详情
(XXIV) 11487 (2S)-1-(tert-Butoxycarbonyl)hexahydro-2-pyridinecarboxylic acid C11H19NO4 详情 详情
(XXV) 15013 1-(tert-butyl) 2-[(1S,3S,4R,5E,7R,8S,9R,10R,12S,13E)-1-[(1R)-2-((1S,3R,4R)-4-[[tert-butyl(diphenyl)silyl]oxy]-3-methoxycyclohexyl)-1-methylethyl]-14-iodo-8-methoxy-3,9-bis[(4-methoxybenzyl)oxy]-4,6,10,12-tetramethyl-7-[(triisopropylsilyl)oxy]-5,13-tetradecadienyl] (2S)-1,2-piperidinedicarboxylate C81H124INO12Si2 详情 详情

合成路线9

The new intermediates, the oxazolidinone (XX) and the aldehyde (XXI), are obtained as follows: Oxazolidinone (XX): The ring opening of cyclohexane epoxide (XXVI) with methanol and CSA followed by silylation with tert-butyldimethylsilyl trifluoromethanesulfonate in dichloromethane gives compound (XXVII), which is debenzylated by hydrogenolysis and oxidized with oxalyl chloride to the cyclohexanone (XXVIII). Dehydrogenation of (XXVIII) by treatment with lithium diiosopropylamide (LDA), tosyl chloride and palladium diacetate yields the cyclohexenone (XXIX), which is reduced with LiBH4 - CeCl3 in methanol/THF to the cyclohexenol (XXX). The condensation of (XXX) with dimethylacetamide diethylacetal (XXXI) in refluxing xylene affords the cyclohexylacetamide (XXXII), which is reduced with lithium triethylborohydride in THF and with H2 over Pd/C in ethanol to give the cyclohexylethanol (XXXIII). The dehydration of (XXXIII) through a selenium derivative yields the vinyl compound (XXXIV), which is oxidized with ozone to the aldehyde (XXXV). Finally, the condensation of (XXXV) with the phosphonate (XXXVI) by means of IEN and LiCl in acetonitrile followed by a desilylation with HF and silylation with tert-butyldiphenylsilyl chloride in DMF yields the oxazolidinone (XX) (see K.C. Nicolau et al., J Chem Soc Chem Commun 1993, 7: 619). (1,2)

1 Nicolaou, K.C.; Piscopio, A.D.; Bertinato, P.; Chakraborty, T.K.; Minowa, N.; Koide, K.; Total Synthesis of Rapamycin. Chemistry (Weinheim) 1995, 1, 5, 318.
2 Nicolaou, K.C.; Chakraborty, T.K.; Piscopio, A.D.; Minowa, N.; Bertinato, P.; Total synthesis of rapamycin. J Am Chem Soc 1993, 115, 10, 4419.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(XX) 15008 (4R,5S)-3-[3-((1S,3R)-4-[[tert-butyl(diphenyl)silyl]oxy]-3-methoxycyclohexyl)propanoyl]-4-methyl-5-phenyl-1,3-oxazolidin-2-one C36H45NO5Si 详情 详情
(XXVI) 15014 benzyl (1S,2R,6S)-7-oxabicyclo[4.1.0]hept-2-yl ether; (1S,2R,6S)-2-(benzyloxy)-7-oxabicyclo[4.1.0]heptane C13H16O2 详情 详情
(XXVII) 15015 benzyl (1R,2S,3R)-2-[[tert-butyl(dimethyl)silyl]oxy]-3-methoxycyclohexyl ether; [[(1S,2R,6R)-2-(benzyloxy)-6-methoxycyclohexyl]oxy](tert-butyl)dimethylsilane C20H34O3Si 详情 详情
(XXVIII) 15016 (2S,3R)-2-[[tert-butyl(dimethyl)silyl]oxy]-3-methoxycyclohexanone C13H26O3Si 详情 详情
(XXIX) 15017 (5R,6S)-6-[[tert-butyl(dimethyl)silyl]oxy]-5-methoxy-2-cyclohexen-1-one C13H24O3Si 详情 详情
(XXX) 15018 (1S,5R,6R)-6-[[tert-butyl(dimethyl)silyl]oxy]-5-methoxy-2-cyclohexen-1-ol C13H26O3Si 详情 详情
(XXXI) 15019 N-(1,1-diethoxyethyl)-N,N-dimethylamine; 1,1-diethoxy-N,N-dimethyl-1-ethanamine C8H19NO2 详情 详情
(XXXII) 15020 2-((1R,3R,4R)-4-[[tert-butyl(dimethyl)silyl]oxy]-3-methoxycyclohexyl)-N,N-dimethylacetamide C17H35NO3Si 详情 详情
(XXXIII) 15021 2-((1S,3R,4R)-4-[[tert-butyl(dimethyl)silyl]oxy]-3-methoxycyclohexyl)-1-ethanol C15H32O3Si 详情 详情
(XXXIV) 15022 tert-butyl(dimethyl)silyl (1R,2R,4R)-2-methoxy-4-vinylcyclohexyl ether; tert-butyl[[(1R,2R,4R)-2-methoxy-4-vinylcyclohexyl]oxy]dimethylsilane C15H30O2Si 详情 详情
(XXXV) 15023 (1R,3R,4R)-4-[[tert-butyl(dimethyl)silyl]oxy]-3-methoxycyclohexanecarbaldehyde C14H28O3Si 详情 详情
(XXXVI) 15024 diethyl 2-[(4R,5S)-4-methyl-2-oxo-5-phenyl-1,3-oxazolan-3-yl]-2-oxoethylphosphonate C16H22NO6P 详情 详情

合成路线10

Aldehyde (XXI): The condensation of oxazolidinone (XXXVII) with aldehyde (XXXVIII) by means of dibutylboron trifluoromethanesulfonate in dichloromethane gives compound (XXXIX), which is reduced with LiBH4, tosyl chloride and lithium triethylborohydride as before, yielding the alcohol (XL). The deprotection of (XL) with tetrabutylammonium fluoride in THF followed by formation of a dioxane ring with p-methoxybenzaldehyde diethyl acetal and CSA in dichloromethane affords compound (XLI), which is submitted to a reductive ring opening with diiosbutylaluminum hydride in dichloromethane, followed by an oxidation with oxalyl chloride in DMSO/dichloromethane, yielding the aldehyde (XLII). The condensation of (XLII) with the unsaturated iodo compound (XLIII) by means of CrCl2 in DMSO gives the hydroxy derivative (XLIV), which is finally silylated with triisopropylsilyl trifluoromethanesulfonate in dichloromethane, selectively desilylated with HF - pyridine and oxidized with oxalyl chloride in DMSO/dichloromethane to the intermediate aldehyde (XXI) (see K.C. Nicolau et al., J Chem Soc Chem Commun 1993, 7: 619). The intermediate (XLIII) is prepared by ozonolysis of the protected unsaturated diol (XLV), followed by reaction with dimethylsulfide and tetrabromomethane - triphenylphosphine to obtain an acetylenic intermediate, which is methylated with butyllithium and methyl iodide to the acetylene (XLVI). Finally, this compound is iodinated with iodine and (cyclopentadienyl)2ZrHCl in dichloromethane to the intermediate (XLIII) (see K.C. Nicolau et al., J Chem Soc Chem Commun 1993, 7: 619). (1,2)

1 Nicolaou, K.C.; Piscopio, A.D.; Bertinato, P.; Chakraborty, T.K.; Minowa, N.; Koide, K.; Total Synthesis of Rapamycin. Chemistry (Weinheim) 1995, 1, 5, 318.
2 Nicolaou, K.C.; Chakraborty, T.K.; Piscopio, A.D.; Minowa, N.; Bertinato, P.; Total synthesis of rapamycin. J Am Chem Soc 1993, 115, 10, 4419.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(XXI) 15009 (3S,4R,5E,7R,8S,9R,10R,12S)-8-methoxy-3,9-bis[(4-methoxybenzyl)oxy]-4,6,10,12-tetramethyl-7-[(triisopropylsilyl)oxy]-5,13-tetradecadienal C44H70O7Si 详情 详情
(XXXVII) 15025 (4R,5S)-4-methyl-3-[(4S)-4-methyl-5-hexenoyl]-5-phenyl-1,3-oxazolan-2-one C17H21NO3 详情 详情
(XXXVIII) 15026 (2R)-3-[[tert-butyl(diphenyl)silyl]oxy]-2-methoxypropanal C20H26O3Si 详情 详情
(XXXIX) 15027 (4R,5S)-3-[(2R,4S)-2-((1R,2R)-3-[[tert-butyl(diphenyl)silyl]oxy]-1-hydroxy-2-methoxypropyl)-4-methyl-5-hexenoyl]-4-methyl-5-phenyl-1,3-oxazolidin-2-one C37H47NO6Si 详情 详情
(XL) 15028 (2R,3R,4R,6S)-1-[[tert-butyl(diphenyl)silyl]oxy]-2-methoxy-4,6-dimethyl-7-octen-3-ol C27H40O3Si 详情 详情
(XLI) 15029 4-[(4R,5R)-4-[(1R,3S)-1,3-dimethyl-4-pentenyl]-5-methoxy-1,3-dioxan-2-yl]phenyl methyl ether; (4R,5R)-4-[(1R,3S)-1,3-dimethyl-4-pentenyl]-5-methoxy-2-(4-methoxyphenyl)-1,3-dioxane C19H28O4 详情 详情
(XLII) 15030 (2S,3R,4R,6S)-2-methoxy-3-(4-methoxybenzyl)-4,6-dimethyl-7-octenal C19H28O3 详情 详情
(XLIII) 15031 tert-butyl(dimethyl)silyl (3S,4S,5E)-6-iodo-3-(4-methoxybenzyl)-4-methyl-5-heptenyl ether; tert-butyl[[(3S,4S,5E)-6-iodo-3-(4-methoxybenzyl)-4-methyl-5-heptenyl]oxy]dimethylsilane C22H37IO2Si 详情 详情
(XLIV) 15032 (3S,4S,5E,7R,8S,9R,10R,12S)-1-[[tert-butyl(dimethyl)silyl]oxy]-8-methoxy-3,9-bis(4-methoxybenzyl)-4,6,10,12-tetramethyl-5,13-tetradecadien-7-ol C41H66O5Si 详情 详情
(XLV) 15033 tert-butyl[[(3S,4R)-3-(4-methoxybenzyl)-4-methyl-5-hexenyl]oxy]dimethylsilane; tert-butyl(dimethyl)silyl (3S,4R)-3-(4-methoxybenzyl)-4-methyl-5-hexenyl ether C21H36O2Si 详情 详情
(XLVI) 15034 tert-butyl(dimethyl)silyl (3S,4S)-3-(4-methoxybenzyl)-4-methyl-5-heptynyl ether; tert-butyl[[(3S,4S)-3-(4-methoxybenzyl)-4-methyl-5-heptynyl]oxy]dimethylsilane C22H36O2Si 详情 详情

合成路线11

A total synthesis of rapamycin has been described: The condensation of the iodo-compound (I) with dithiane (II) by means of tert-butyllithium in THF followed by elimination of the acetal group with trichloroacetic acid gives the aldehyde (III), which is condensed with the dithiane (IV) by means of tert-butyllithium in THF, and the resulting compound methylated with NaH and methyl iodide to afford the acetal (V) as a diastereomeric mixture (in the newly formed methoxy group) that was resolved by flash chromatography. The sequential reaction of (V) first with p-toluenesulfonic acid to hydrolyze the acetal group, and then with CBr4 in THF/HMPT and finally with butyllithium in THF gives the terminal acetylene derivative (VI). Elimination of the dithiane and PMB groups, and reaction with tributyl tin hydride affords the trans-vinylene alcohol (VII), which is esterified with piperidine carboxylic acid (VIII) by means of 1-[3-(dimethylamino)propyl]-3-ethylcarbodiimide (EDC) and DMAP in dichloromethane yielding the condensation ester (IX). Finally, this compound is submitted to an intramolecular Stille cyclization with the tris(2-furyl)phosphine palladium dichloride complex in DMF/THF, which after desilylation with tetrabutylammonium fluoride (TBAF) and HF.pyridine afforded rapamycin.

1 McCauley, J.A.; Leahy, J.W.; Smith, A.B.; Leazer, J.L.; Maleczka, R.E.; Condon, S.M.; Total synthesis of rapamycin and demethoxyrapamycin. J Am Chem Soc 1995, 117, 19, 5407.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 15035 ([(1S,2R,4S)-4-[(2R,3R)-4-iodo-3-(4-methoxybenzyl)-2-methylbutyl]-2-methoxycyclohexyl]oxy)(triisopropyl)silane; (1S,2R,4S)-4-[(2R,3R)-4-iodo-3-(4-methoxybenzyl)-2-methylbutyl]-2-methoxycyclohexyl triisopropylsilyl ether C29H51IO3Si 详情 详情
(II) 15036 tert-butyl[[(1R,2E,4R)-1-(dimethoxymethyl)-4-(1,3-dithian-2-yl)-2-methyl-2-pentenyl]oxy]dimethylsilane; tert-butyl(dimethyl)silyl (1R,2E,4R)-1-(dimethoxymethyl)-4-(1,3-dithian-2-yl)-2-methyl-2-pentenyl ether C19H38O3S2Si 详情 详情
(III) 15037 (2R,3E,5R)-2-[[tert-butyl(dimethyl)silyl]oxy]-5-[2-((2S,3R)-2-(4-methoxybenzyl)-4-[(1S,3R,4R)-3-methoxy-4-[(triisopropylsilyl)oxy]cyclohexyl]-3-methylbutyl)-1,3-dithian-2-yl]-3-methyl-3-hexenal C46H82O5S2Si2 详情 详情
(IV) 15038 (2S,4R)-4-(1,3-dithian-2-yl)-1-methoxy-2-methylpentyl methyl ether; 2-[(1R,3S)-4,4-dimethoxy-1,3-dimethylbutyl]-1,3-dithiane C12H24O2S2 详情 详情
(V) 15039 tert-butyl(dimethyl)silyl (1R,2E,4R)-1-[(R)-[2-[(1R,3S)-4,4-dimethoxy-1,3-dimethylbutyl]-1,3-dithian-2-yl](methoxy)methyl]-4-[2-((2R,3R)-2-(4-methoxybenzyl)-4-[(1S,3R,4R)-3-methoxy-4-[(triisopropylsilyl)oxy]cyclohexyl]-3-methylbutyl)-1,3-dithian-2-yl]-2-methyl-2-pentenyl ether; tert-butyl([(1R,2E,4R)-1-[(R)-[2-[(1R,3S)-4,4-dimethoxy-1,3-dimethylbutyl]-1,3-dithian-2-yl](methoxy)methyl]-4-[2-((2R,3R)-2-(4-methoxybenzyl)-4-[(1S,3R,4R)-3-methoxy-4-[(triisopropylsilyl)oxy]cyclohexyl]-3-methylbutyl)-1,3-dithian-2-yl]-2-methyl-2-pentenyl]oxy)dimethylsilane C59H108O7S4Si2 详情 详情
(VI) 15040 tert-butyl([(1R,2E,4R)-1-[(R)-[2-[(1R,3S)-1,3-dimethyl-4-pentynyl]-1,3-dithian-2-yl](methoxy)methyl]-4-[2-((2S,3R)-2-(4-methoxybenzyl)-4-[(1S,3R,4R)-3-methoxy-4-[(triisopropylsilyl)oxy]cyclohexyl]-3-methylbutyl)-1,3-dithian-2-yl]-2-methyl-2-pentenyl]oxy)dimethylsilane; tert-butyl(dimethyl)silyl (1R,2E,4R)-1-[(R)-[2-[(1R,3S)-1,3-dimethyl-4-pentynyl]-1,3-dithian-2-yl](methoxy)methyl]-4-[2-((2S,3R)-2-(4-methoxybenzyl)-4-[(1S,3R,4R)-3-methoxy-4-[(triisopropylsilyl)oxy]cyclohexyl]-3-methylbutyl)-1,3-dithian-2-yl]-2-methyl-2-pentenyl ether C58H102O5S4Si2 详情 详情
(VII) 15041 (2R,3S,6R,7E,9R,10R,12R,14S,15E)-9-[[tert-butyl(dimethyl)silyl]oxy]-3-hydroxy-10-methoxy-1-[(1S,3R,4R)-3-methoxy-4-[(triisopropylsilyl)oxy]cyclohexyl]-2,6,8,12,14-pentamethyl-16-(tributylstannyl)-7,15-hexadecadiene-5,11-dione C56H110O7Si2Sn 详情 详情
(VIII) 15042 (2S)-1-(2-[(2S,3R,6S)-6-[(2S,3E,5E)-6-iodo-2-methoxy-3-methyl-3,5-hexadienyl]-3-methyl-2-[(triethylsilyl)oxy]tetrahydro-2H-pyran-2-yl]-2-oxoacetyl)-2-piperidinecarboxylic acid C28H46INO7Si 详情 详情
(IX) 15043 (1S,4R,5E,7R,8R,10R,12S,13E)-7-[[tert-butyl(dimethyl)silyl]oxy]-8-methoxy-1-((1R)-2-[(1S,3R,4R)-3-methoxy-4-[(triisopropylsilyl)oxy]cyclohexyl]-1-methylethyl)-4,6,10,12-tetramethyl-3,9-dioxo-14-(tributylstannyl)-5,13-tetradecadienyl (2S)-1-(2-[(2S,3R,6S)-6-[(2S,3E,5E)-6-iodo-2-methoxy-3-methyl-3,5-hexadienyl]-3-methyl-2-[(triethylsilyl)oxy]tetrahydro-2H-pyran-2-yl]-2-oxoacetyl)-2-piperidinecarboxylate C84H154INO13Si3Sn 详情 详情

合成路线12

The intermediate piperidine carboxylic acid (VIII) was obtained as follows: The acetylene orthoester (X) was submitted sequentially to hydrolysis with acetic acid, silylation with TBS-Cl, reduction with DIBAL and Swern oxidation to give the acetylenic aldehyde (XI), which was condensed with 1-acetylpiperidine-2-carboxylic acid (XII), and the resulting compound was esterified with diazomethane, submitted to a Dess-Martin oxidation yielding a tricarbonyl compound that, without isolation was desilylated with HF yielding the cyclic hemiketal (XIII). This hemiketal was silylated with TES-triflate and submitted to hydrostannylation with tributyl tin hydride and AIBN, and tin - iodine exchange with I2/LiI in pyridine at 130 C to afford the desired (E,E)-divinylene iodide fragment (VIII). The syntheses of the starting fragments (I), (II), (IV), (X) and (XII) has already been reported (see Smith, A.B. et al. Tetrahedron Lett 1994, 35(28): 4907 and Smith, A.B. et al. Tetrahedron Lett 1994, 35(28): 4911).

1 McCauley, J.A.; Leahy, J.W.; Smith, A.B.; Leazer, J.L.; Maleczka, R.E.; Condon, S.M.; Total synthesis of rapamycin and demethoxyrapamycin. J Am Chem Soc 1995, 117, 19, 5407.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(VIII) 15042 (2S)-1-(2-[(2S,3R,6S)-6-[(2S,3E,5E)-6-iodo-2-methoxy-3-methyl-3,5-hexadienyl]-3-methyl-2-[(triethylsilyl)oxy]tetrahydro-2H-pyran-2-yl]-2-oxoacetyl)-2-piperidinecarboxylic acid C28H46INO7Si 详情 详情
(X) 15044 [(E,5S)-5-methoxy-4-methyl-6-[(2R,3R,7S,10R)-2,3,10-trimethyl-1,4,6-trioxaspiro[4.5]dec-7-yl]-3-hexen-1-ynyl](trimethyl)silane; methyl (1S,2E)-2-methyl-5-(trimethylsilyl)-1-[[(2R,3R,7S,10R)-2,3,10-trimethyl-1,4,6-trioxaspiro[4.5]dec-7-yl]methyl]-2-penten-4-ynyl ether C21H36O4Si 详情 详情
(XI) 15045 (2R,5S,7S,8E)-5-[[tert-butyl(dimethyl)silyl]oxy]-7-methoxy-2,8-dimethyl-11-(trimethylsilyl)-8-undecen-10-ynal C23H44O3Si2 详情 详情
(XII) 15046 (2S)-1-acetylhexahydro-2-pyridinecarboxylic acid C8H13NO3 详情 详情
(XIII) 15047 methyl (2S)-1-(2-[(2R,3R,6S)-2-hydroxy-6-[(2S,3E)-2-methoxy-3-methyl-3-hexen-5-ynyl]-3-methyltetrahydro-2H-pyran-2-yl]-2-oxoacetyl)-2-piperidinecarboxylate C23H33NO7 详情 详情
Extended Information